Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary R Cutter

Showing results (141-150 of 296) with videos related to

Pageof 30
Sort By:
Contemporary Clinical Trials|December 19, 2022
Randomized controlled trial of the behavioral intervention for increasing physical activity in multiple sclerosis project: Secondary, patient-reported outcomesRobert W Motl, Brian M Sandroff, Lara A Pilutti, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 24, 2021
Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson DiseaseZhaoqi Yan, Wei Yang, Hairong Wei, et al.
Multiple Sclerosis and Related Disorders|August 16, 2023
Randomized controlled trial of the behavioral intervention for physical activity in multiple sclerosis project: Social cognitive theory variables as mediatorsRobert W Motl, Ariel Kidwell-Chandler, Brian M Sandroff, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 25, 2014
The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic reviewRuth Ann Marrie, Nadia Reider, Olaf Stuve, et al.
Epilepsy & Behavior : E&B|August 6, 2019
Drug-drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access ProgramTyler E Gaston, E Martina Bebin, Gary R Cutter, et al.
Journal of Studies on Alcohol and Drugs|April 7, 2021
Randomized Trial Testing an Online Responsible Vendor Training in Recreational Marijuana Stores in the United StatesDavid B Buller, W Gill Woodall, Robert Saltz, et al.
Neurology|May 26, 2021
Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility TrialMarcus W Koch, Kayla Sage, Sharanjit Kaur, et al.
Clinical Gerontologist|April 29, 2017
Neurocognitive Predictors of Declining Financial Capacity in Persons with Mild Cognitive ImpairmentLindsay M Niccolai, Kristen L Triebel, Adam Gerstenecker, et al.
Journal of Medical Internet Research|October 19, 2007
Effect of emailed messages on return use of a nutrition education website and subsequent changes in dietary behaviorW Gill Woodall, David B Buller, Laura Saba, et al.
Multiple Sclerosis and Related Disorders|September 9, 2015
Causes of death among persons with multiple sclerosisGary R Cutter, Jeffrey Zimmerman, Amber R Salter, et al.
Pageof 30

Showing results (141-150 of 296) with videos related to

Sort By:
Pageof 30
Contemporary Clinical Trials|December 19, 2022
Randomized controlled trial of the behavioral intervention for increasing physical activity in multiple sclerosis project: Secondary, patient-reported outcomesRobert W Motl, Brian M Sandroff, Lara A Pilutti, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 24, 2021
Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson DiseaseZhaoqi Yan, Wei Yang, Hairong Wei, et al.
Multiple Sclerosis and Related Disorders|August 16, 2023
Randomized controlled trial of the behavioral intervention for physical activity in multiple sclerosis project: Social cognitive theory variables as mediatorsRobert W Motl, Ariel Kidwell-Chandler, Brian M Sandroff, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 25, 2014
The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic reviewRuth Ann Marrie, Nadia Reider, Olaf Stuve, et al.
Epilepsy & Behavior : E&B|August 6, 2019
Drug-drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access ProgramTyler E Gaston, E Martina Bebin, Gary R Cutter, et al.
Journal of Studies on Alcohol and Drugs|April 7, 2021
Randomized Trial Testing an Online Responsible Vendor Training in Recreational Marijuana Stores in the United StatesDavid B Buller, W Gill Woodall, Robert Saltz, et al.
Neurology|May 26, 2021
Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility TrialMarcus W Koch, Kayla Sage, Sharanjit Kaur, et al.
Clinical Gerontologist|April 29, 2017
Neurocognitive Predictors of Declining Financial Capacity in Persons with Mild Cognitive ImpairmentLindsay M Niccolai, Kristen L Triebel, Adam Gerstenecker, et al.
Journal of Medical Internet Research|October 19, 2007
Effect of emailed messages on return use of a nutrition education website and subsequent changes in dietary behaviorW Gill Woodall, David B Buller, Laura Saba, et al.
Multiple Sclerosis and Related Disorders|September 9, 2015
Causes of death among persons with multiple sclerosisGary R Cutter, Jeffrey Zimmerman, Amber R Salter, et al.
Pageof 30